Medicine
Calcium acetate 667 mg capsule
Calcium acetate 667 mg capsule is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°-25°C (68°-77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Calcium acetate
- Brand
- Sold under the generic name
- Strength
- 667 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 200 capsules, 1000 capsules, 13600 capsules and 35 more
- Manufacturers
- Avet PharmaceuticalsIndiaCiplaIndiaProficient RxAmneal Pharmaceuticals of New YorkChartwell RXAmerican Health PackagingExelan PharmaceuticalsHikma PharmaceuticalsMajor PharmaceuticalsAvKARE
- Origin register
- US FDA, United States
- Storage
- Store at 20°-25°C (68°-77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE07 Calcium acetate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 February 2008
- Identifiers
- RxCUI 359296DailyMed set ID ce650ba5-fb42-e444-e053-2a95a90a075a, 52e35dd6-db95-98e6-e063-6294a90ab801, 781c3f1f-b622-418b-8c0e-3407e9b90656 +17NDC 16571-813, 50268-203, 62135-191 +17Application ANDA211038, ANDA203179, ANDA091312 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 200 capsule in 1 bottle | 23155-531-02 | Avet PharmaceuticalsIndia | 7 July 2015 |
| 1000 capsule in 1 bottle | 23155-531-10 | Avet PharmaceuticalsIndia | 7 July 2015 |
| 13600 capsule in 1 container | 23155-531-18 | Avet PharmaceuticalsIndia | 7 July 2015 |
| 60 capsule in 1 bottle | 69097-862-03 | CiplaIndia | 26 July 2016 |
| 200 capsule in 1 bottle | 69097-862-83 | CiplaIndia | 26 July 2016 |
| 100 capsule in 1 bottle | 53746-590-01 | Amneal Pharmaceuticals of New York | 8 October 2014 |
| 500 capsule in 1 bottle | 53746-590-05 | Amneal Pharmaceuticals of New York | 8 October 2014 |
| 200 capsule in 1 bottle | 53746-590-20 | Amneal Pharmaceuticals of New York | 8 October 2014 |
| 200 capsule in 1 bottle | 62135-191-22 | Chartwell RX | 29 June 2018 |
| 30 capsule in 1 bottle | 62135-191-30 | Chartwell RX | 29 June 2018 |
| 750 capsule in 1 bottle | 62135-191-73 | Chartwell RX | 29 June 2018 |
| 200 capsule in 1 bottle | 76282-377-02 | Exelan Pharmaceuticals | 14 April 2014 |
| 60 capsule in 1 bottle | 76282-377-60 | Exelan Pharmaceuticals | 14 April 2014 |
| 30 capsule in 1 bottle | 0054-0088-13 | Hikma Pharmaceuticals | 28 February 2008 |
| 200 capsule in 1 bottle | 0054-0088-26 | Hikma Pharmaceuticals | 28 February 2008 |
| 200 capsule in 1 bottle | 75834-323-02 | Nivagen Pharmaceuticals | 7 December 2023 |
| 200 capsule in 1 bottle, plastic | 16571-813-20 | Rising Pharma Holdings | 1 November 2021 |
| 200 capsule in 1 bottle | 76483-086-00 | Square Pharmaceuticals | 31 May 2023 |
| 50 blister pack in 1 carton / 1 capsule in 1 blister pack | 60687-589-65 | American Health Packaging | 5 July 2026 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 68084-479-01 | American Health Packaging | 18 July 2013 |
| 200 capsule in 1 bottle | 73190-031-20 | AvKARE | 21 May 2025 |
| 50 blister pack in 1 box / 1 capsule in 1 blister pack | 50268-203-15 | AvPAK | 28 May 2026 |
| 10 blister pack in 1 bag / 1 capsule in 1 blister pack | 55154-4169-0 | Cardinal Health | 26 February 2008 |
| 50 blister pack in 1 carton / 1 capsule in 1 blister pack | 0904-7119-06 | Major Pharmaceuticals | 26 February 2008 |
| 100 blister pack in 1 carton / 1 capsule in 1 blister pack | 0904-7119-61 | Major Pharmaceuticals | 26 February 2008 |
| 200 capsule in 1 bottle, plastic | 72789-422-97 | PD-Rx Pharmaceuticals | 16 July 2024 |
| 100 capsule in 1 bottle | 82804-968-00 | Proficient Rx | 25 June 2025 |
| 20 capsule in 1 bottle | 82804-968-20 | Proficient Rx | 25 June 2025 |
| 30 capsule in 1 bottle | 82804-968-30 | Proficient Rx | 25 June 2025 |
| 500 capsule in 1 bottle | 82804-968-55 | Proficient Rx | 25 June 2025 |
| 60 capsule in 1 bottle | 82804-968-60 | Proficient Rx | 25 June 2025 |
| 240 capsule in 1 bottle | 82804-968-64 | Proficient Rx | 25 June 2025 |
| 120 capsule in 1 bottle | 82804-968-72 | Proficient Rx | 25 June 2025 |
| 180 capsule in 1 bottle | 82804-968-78 | Proficient Rx | 25 June 2025 |
| 90 capsule in 1 bottle | 82804-968-90 | Proficient Rx | 25 June 2025 |
| 30 capsule in 1 blister pack | 70518-4299-0 | Remedyrepack | 2 March 2025 |
| 30 capsule in 1 blister pack | 0615-8632-39 | Vangard Labs | 16 April 2026 |
| 200 capsule in 1 bottle | 69367-411-02 | Westminster Pharmaceuticals | 13 June 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1990 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Calcium acetate
Clinical summary
Calcium acetate is a blood coagulation factor indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). It is available as capsules and tablets for oral use. MedsAcross supplies Calcium acetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Calcium acetateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Calcium Acetate prescribing information (Rising Pharma Holdings) · U.S. National Library of Medicine, DailyMed
Need Calcium acetate 667 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.